Bradykinin (Part-02)= Pathophysiology of Bradykinin | Bradykinin Pathophysiology | Bradykinin
Solution- Pharmacy Solution- Pharmacy
976K subscribers
16,587 views
469

 Published On Nov 6, 2019

Download "Solution Pharmacy" Mobile App to Get All Uploaded Notes, Model Question Papers, Answer Papers, Online Test and other GPAT Materials - https://play.google.com/store/apps/de...

Bradykinin (Greek brady-, slow; -kinin, kīn(eîn) to move) is an inflammatory mediator. It is a peptide that causes blood vessels to dilate (enlarge) via the release of prostacyclin, nitric oxide, and Endothelium-Derived Hyperpolarizing Factor. Bradykinin is a physiologically and pharmacologically active peptide of the kinin group of proteins, consisting of nine amino acids.

A class of drugs called angiotensin-converting enzyme (ACE) inhibitors increase bradykinin levels by inhibiting its degradation, thereby increasing its blood pressure-lowering effect. ACE inhibitors are FDA approved for the treatment of hypertension and heart failure.

Bradykinin is a potent endothelium-dependent vasodilator and a mild diuretic, which may cause a lowering of the blood pressure. It also causes contraction of non-vascular smooth muscle in the bronchus and gut, increases vascular permeability and is also involved in the mechanism of pain.

Get in touch with the solution by just clicking following links-

Facebook Group-   / solutionpharamcy  
Facebook Page-   / pharmavideo  
New channel (Pharmacy Dictionary) -    / @pharmacydictionary  
Instagram-   / solutionpharmacy  
E-Mail for official and other work - [email protected]
LinkedIn-   / pushpendrakpatel  
#solutionpharmacy #Pharmacologyclass #GPATonlinetest

show more

Share/Embed